We recently compiled a list of the 14 Best 52-Week High Stocks To Buy According to Analysts. In this article, we are going to ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Read here for highlights on Royalty Pharma's strategic updates, share repurchase program, and dividend increase with ...

Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies.

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...